BACM
ASPX

Blue Arrow Capital Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Blue Arrow Capital Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-15,000
Closed -$385K – 272
2014
Q3 		$385K Buy
+15,000
New +$319K 0.04% 166

Other funds holding ASPX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Blue Arrow Capital Management's ASPX Position: Q4 2014 in Review

Blue Arrow Capital Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q4 2014, closing a stake of 15,000 shares — an estimated $385K sold.

Blue Arrow Capital Management first reported a position in ASPX in Q3 2014 and held it in 1 quarter. The position peaked at $385K in Q3 2014. 89 funds tracked by Wall St. Rank hold ASPX as of Q4 2014.

  • Blue Arrow Capital Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Blue Arrow Capital Management sold 15,000 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q4 2014, an estimated $385K.
  • Blue Arrow Capital Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 1 quarter.
  • Blue Arrow Capital Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $385K in Q3 2014.
  • 89 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on Blue Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.